Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Millenson

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 15, 2000
Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lungR J Schilder, M Goldberg, M M Millenson, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 29, 2016
Low Level of Blood CD4<sup>+</sup> T Cells Is an Independent Predictor of Inferior Progression-free Survival in Diffuse Large B-cell LymphomaJulia Judd, Essel Dulaimi, Tianyu Li, et al.
Healthplan|October 28, 1999
Health 2000: the next millennium ... panel discussionM Millenson, D Young, M Wood, et al.
Leukemia Research|August 24, 2013
Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphomaDanielle Shafer, Mitchell R Smith, Hossein Borghaei, et al.
The Journal of Investigative Dermatology|December 17, 2003
Contribution of flow cytometry in the diagnosis of cutaneous lymphoid lesionsHong Wu, Mitchell Smith, Michael M Millenson, et al.
Cancer Genetics|April 8, 2014
Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphomaJianming Pei, Valentin Robu, Madelyn Feder, et al.
Seminars in Oncology|December 1, 1996
Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center NetworkC J Langer, M Millenson, P O'Dwyer, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
Paclitaxel by 1-h infusion in combination with carboplatin in advanced non-small cell lung carcinoma (NSCLC)C J Langer, C A McAleer, C A Bonjo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I trial of multiple cycles of high-dose chemotherapy supported by autologous peripheral-blood stem cellsR J Schilder, S Johnson, J Gallo, et al.
Clinical Lung Cancer|December 10, 2003
Temozolomide in non-small-cell lung cancer: preliminary results of a phase II trial in previously treated patientsChristian S Adonizio, James S Babb, Christine Maiale, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Lung Cancer (Amsterdam, Netherlands)|February 15, 2000
Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lungR J Schilder, M Goldberg, M M Millenson, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 29, 2016
Low Level of Blood CD4<sup>+</sup> T Cells Is an Independent Predictor of Inferior Progression-free Survival in Diffuse Large B-cell LymphomaJulia Judd, Essel Dulaimi, Tianyu Li, et al.
Healthplan|October 28, 1999
Health 2000: the next millennium ... panel discussionM Millenson, D Young, M Wood, et al.
Leukemia Research|August 24, 2013
Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphomaDanielle Shafer, Mitchell R Smith, Hossein Borghaei, et al.
The Journal of Investigative Dermatology|December 17, 2003
Contribution of flow cytometry in the diagnosis of cutaneous lymphoid lesionsHong Wu, Mitchell Smith, Michael M Millenson, et al.
Cancer Genetics|April 8, 2014
Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphomaJianming Pei, Valentin Robu, Madelyn Feder, et al.
Seminars in Oncology|December 1, 1996
Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center NetworkC J Langer, M Millenson, P O'Dwyer, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2000
Paclitaxel by 1-h infusion in combination with carboplatin in advanced non-small cell lung carcinoma (NSCLC)C J Langer, C A McAleer, C A Bonjo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase I trial of multiple cycles of high-dose chemotherapy supported by autologous peripheral-blood stem cellsR J Schilder, S Johnson, J Gallo, et al.
Clinical Lung Cancer|December 10, 2003
Temozolomide in non-small-cell lung cancer: preliminary results of a phase II trial in previously treated patientsChristian S Adonizio, James S Babb, Christine Maiale, et al.
Pageof 5